Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . The Review of Diabetic Studies , [S. l.], v. 6, n. 1, 2023. Disponível em: https://diabeticstudies.org/index.php/RDS/article/view/252. Acesso em: 13 sep. 2025.